BOULDER, Colo. and BOSTON, Oct. 8, 2014 /PRNewswire/ -- BiOptix, while participating in the 12th Annual Discovery on Target Symposia, formally announced its fall 2014 scientific symposia and event schedule. The ambitious schedule includes participation in and presentation of BiOptix data and instrument capabilities at five events which will highlight the BiOptix 404pi as well as recent data and publications generated by the innovative BiOptix Surface Plasmon Resonance platform. BiOptix fall 2014 events will include:
- 12th Annual Discovery on Target Scientific Research Symposium
- American Association of Pharmaceutical Scientists Annual Meeting & Exposition
- 53rd Annual Eastern Analytical Summit
- 3rd Annual Conference of the International Chemical Biology Society
- 25th Annual Antibody Engineering & Therapeutics Summit
“2014 has been a successful year for BiOptix and the BiOptix 404pi in the scientific research marketplace,” commented Ken Wilczek, Vice President, Sales & Marketing for BiOptix. “We have new customers who are generating exciting data and cutting-edge scientific publications using our state-of-the-art SPR platform. BiOptix is proud to be a partner to some of the best research labs in the world and is enthusiastic to continue to share our value proposition at these upcoming events this fall and into 2015.” BiOptix participation will include data presentations, customer speaking engagements and instrumentation demonstrations tailored to targeted segments of the scientific research market. Specific attention at each event will be focused on the unique features and capabilities of the BiOptix 404pi SPR instrument, such as the ability to generate multiple kinetic profiles in a single experiment, the detection of small molecules at extremely low concentrations as well as the capability to produce consistent and repeatable binding data for protein-protein interactions. Additional event details can be found at: www.bioptix.com
About BiOptix
BiOptix Diagnostics is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures, Remeditex and Rusnano. BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interactionwith high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com
BiOptix: Kinetics with Confidence.
SOURCE BiOptix
Help employers find you! Check out all the jobs and post your resume.
